Inactive

Boehringer Ingelheim Venture Fund

Investor type

VC / CVC

Founded

1885

AUM

$350 M

Location

Ingelheim am Rhein, Rhineland-Palatinate, Germany

Investment Ticket

$10-50 m

Investment Stage

Series A Seed Series B

Region of investment

North America Europe Asia Australia and others
Investor profile last updated: 28 August, 2026

Profile

At Boehringer Ingelheim we create value through innovation with one clear goal: to improve the lives of patients. We develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, we focus on long-term performance. We are powered by 52.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is our growth. Want to learn more? Visit www.boehringer-ingelheim.com and join us in our effort to make more health.

Industry

HealthTech Life Sciences Pharmaceuticals Medical Devices Healthcare Services Biotechnology Food and Beverage Foodtech SaaS Software

Boehringer Ingelheim Venture Fund Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Fund I - BIVF
Corporate VC (CVC)
Food and Beverage
Foodtech
Healthcare Services
SaaS
Software
HealthTech
Seed
Series A
North America
Europe
$5-10 m
$250 M
January 2018

Contacts

Name
Title
Email
avatar
Dr. Sven Sommerlatte President
President
s•••@•••
avatar
Jérôme Baudon Executive Director
Executive Director
j•••@•••
Upgrade to see contacts
avatar
26JYZX8mSIHWdgz3 26JYZX8mSIHWdgz3
26JYZX8mSIHWdgz3
avatar
26JYZX8mSIHWdgz3 26JYZX8mSIHWdgz3
26JYZX8mSIHWdgz3
avatar
26JYZX8mSIHWdgz3 26JYZX8mSIHWdgz3
26JYZX8mSIHWdgz3
Investment-team contacts for Boehringer Ingelheim Venture Fund — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund is a venture capital firm that also operates as a corporate VC (CVC). It backs companies at Series A, Seed and Series B, writing tickets of $10-50 m.
Boehringer Ingelheim Venture Fund is located in Ingelheim am Rhein, Rhineland-Palatinate, Germany.
Boehringer Ingelheim Venture Fund was founded in 1885.
Boehringer Ingelheim Venture Fund invests in companies and startups in HealthTech, Life Sciences, Pharmaceuticals, Medical Devices, Healthcare Services, Biotechnology, Food and Beverage, Foodtech, SaaS, Software.
Boehringer Ingelheim Venture Fund invests in companies and startups in North America, Europe, Asia, Australia and others.
Boehringer Ingelheim Venture Fund invests in companies and startups at Series A, Seed, Series B.
Boehringer Ingelheim Venture Fund usually invests $10-50 m on average.
Boehringer Ingelheim Venture Fund has around $350m assets under management.
Boehringer Ingelheim Venture Fund last fund was created/launched in 2018-01-18
Boehringer Ingelheim Venture Fund can be reached through its website boehringer-ingelheim.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Boehringer Ingelheim Venture Fund — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Boehringer Ingelheim Venture Fund directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 28 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.